SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Canaccord Genuity Initiates Coverage On Akoya Biosciences with Buy Rating, Announces Price Target of $25

Canaccord Genuity analyst Max Masucci initiates coverage on Akoya Biosciences (NASDAQ:AKYA) with a Buy rating and announces Price Target of $25.

05/11/2021 10:12
Canaccord Genuity analyst Max Masucci initiates coverage on Akoya Biosciences (NASDAQ:AKYA) with a Buy rating and announces Price Target of $25.